Cholangiocarcinoma is a malignant tumor that develops from mutated epithelial cells of the bile ducts. It is a relatively rare cancer: in Europe and North America it occurs in 1–2 people per 100,000 population per year, although its frequency has been increasing over recent decades. Understanding where the tumor grows and how it is detected helps you avoid feeling lost when you encounter this word in a report.
What cholangiocarcinoma is and where it arises
The bile ducts are tubes through which the liver secretes bile into the small intestine. The tumor originates from their epithelium and, by histological structure, in 90–95% of cases belongs to adenocarcinomas. The disease is more often detected in people aged 50–70 years, with a peak in the eighth decade of life; it occurs somewhat more often in men. In the early stages the disease is minimally symptomatic, so most patients seek care when the tumor is already inoperable.
Types: intrahepatic and extrahepatic cholangiocarcinoma
Tumors are divided by location: intrahepatic (in the ducts within the liver) and extrahepatic (hilar and distal). Cancer of the ducts outside the liver occurs significantly more often. Synonyms for the term are cholangiocellular and cholangiogenic cancer; the name "Klatskin tumor" is sometimes used. According to the National Comprehensive Cancer Network guidelines, cholangiocarcinomas include all tumors arising from the epithelium of the bile ducts; gallbladder tumors are included only in certain sources.
Causes and risk factors
Most patients have no specific risk factors in their history. For Europe and North America, the most significant is primary sclerosing cholangitis: the risk of developing cholangiocarcinoma with it is 10–15%. Other factors include congenital and chronic diseases of the biliary tract (Caroli disease, choledochal cyst), Lynch syndrome, Crohn's disease, smoking, exposure to Thorotrast, and alpha1-antitrypsin deficiency. For the Far East and Southeast Asia, the leading cause is parasitic liver infestations. Gallstone disease, unlike gallbladder cancer, does not increase the risk.
Symptoms: jaundice and other signs
The clinical picture includes jaundice, abdominal pain, impaired liver function, weight loss, fever, generalized itching, and possible changes in the color of stool and urine. These signs are nonspecific and do not confirm the diagnosis on their own.
- Jaundice — yellowing of the skin and whites of the eyes
- Skin itching without an obvious cause
- Abdominal pain
- Weight loss and fever
- Changes in the color of stool and urine
How cholangiocarcinoma is diagnosed
Evaluation may include a physical examination, imaging of the liver and bile ducts, blood tests (including for alkaline phosphatase and bilirubin), and endoscopic methods such as ERCP. To verify the diagnosis, a biopsy with subsequent histological examination of the material is necessary. Only a doctor, based on the totality of data, determines which specific tests are needed in a particular case.
Complications and when emergency medical help is needed
Untreated cholangiocarcinoma is a fatal disease; radical surgery remains the only potentially curative method that offers hope of cure. Impaired bile outflow may be accompanied by severe jaundice and itching, which requires medical evaluation.
The presence of the diagnosis alone is not a reason to call an ambulance; 103 or 112 — if the condition is life-threatening (for example, the person loses consciousness or cannot breathe).
This material is for reference purposes: it explains the essence of the disease but does not replace consultation with a doctor, who evaluates the specific situation.
Sources
Update history
Reader reviews
No reviews yet — tell us whether this article was helpful.
Leave a review
This content is for reference and does not replace a doctor's consultation. Medical disclaimer